[ad_1]
The US Food and Drug Administration has issued warnings to two other companies selling the controversial kratom supplement, saying the crackdown by the agency continues to face difficulties almost a year later.
Chillin Mix Kratom, one of the companies, announces cheap prices and wholesale quantities of the supplement – it sells more than two pounds of kratom powder for only $ 65, while the other, Mitra Distributing, operates another website . .
Both claim illegally that their products can be used as treatment or treatment for opioid addiction and withdrawal symptoms, according to the FDA's warning letters dated September 4 and made public Tuesday.
These have been common assertions made about kratom, which comes from an Asian plant and has been made available in the form of pill, powder and other forms.
But the FDA decided earlier this year that kratom should not be used for any of these conditions, as there is no evidence that it is safe and effective; the regulator also concluded that the supplement contains addictive opioids.
The FDA has warned repeatedly since last fall about the product and safety issues associated with it, including declaring earlier this year that 44 deaths had been associated with the product.
Lily: More evidence that the opioid epidemic is only worsening
"Simply, selling these unapproved kratom products with claims that they can treat withdrawal and opioid dependence and other serious medical conditions is a violation of federal law," the FDA said in a statement. a statement. "Yet, despite our previous warnings and regulatory and enforcement actions, we continue to find traders who are actively selling kratom with unsubstantiated claims."
The two companies in question, Chillin Mix Kratom and Mitra Distributing, also claimed that their kratom products could treat conditions such as obesity, depression, alcoholism and hypertension, according to the FDA.
The United States has been living in an opioid epidemic for several years, and the Centers for Disease Control and Prevention report that overdoses of opioids kill more than 600,000 people between 1999 and 2016.
Despite this, public health experts warn that many barriers, including financial ones, continue to hinder access to opioid treatment. There has also been little progress in developing a better painkiller.
Related: Opioids ravage the United States, but they are still the best painkiller we have and the family tragedy of the official Medicaid led him to tackle the opioid crisis head-on.
US agencies strive to improve access to FDA-approved treatments for opioid dependence, according to FDA statement, and regulators can not allow kratom products to prevent affected people from having effective drugs.
Source link
